{"DataElement":{"publicId":"3308386","version":"1","preferredName":"Immunotherapy Trastuzumab Dose Administered Specify","preferredDefinition":"the free-text field to specify the number of doses or quantity trastuzumab, a treatment to stimulate or restore the ability of the immune system to fight infections and other diseases using a humanized recombinant monoclonal antibody directed against the HER2- receptor protein, having been administered.","longName":"3308305v1.0:2018810v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3308305","version":"1","preferredName":"Immunotherapy Trastuzumab Dose Administered","preferredDefinition":"information related to the doses or quantity trastuzumab, a treatment to stimulate or restore the ability of the immune system to fight infections and other diseases using a humanized recombinant monoclonal antibody directed against the HER2- receptor protein.","longName":"2554222v1.0:3308303v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2554222","version":"1","preferredName":"Immunotherapy","preferredDefinition":"Therapy that designed to induce changes of patient's immune status in treatment of disease. The concept encompassing various treatment modalities including active and passive immunization, treatment with immunopotentiators, immunosuppressants and nonspecific systemic immunostimulators and adjuvants, desensitization to any allergens, bone marrow transplantation, thymus implantation.","longName":"C15262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"249AEAAA-2E20-0D4D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-14","endDate":null,"createdBy":"UMLLOADER_TUMOR","dateCreated":"2006-12-14","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3308303","version":"1","preferredName":"Trastuzumab Dose Administered","preferredDefinition":"A humanized recombinant monoclonal antibody directed against the HER2- receptor protein.  Trastuzumab binds to the extracellular domain of the growth factor protein HER2, thereby inhibiting proliferation of HER2 overexpressing tumor cells.  Binding with HER2 protein also initiates an antibody-dependent cell cytotoxicity.(NCI):The amount of medicine taken, or radiation given, at one time.:The act of having given something (e.g., a medication or test).","longName":"C1647:C25488:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trastuzumab","conceptCode":"C1647","definition":"A recombinant humanized monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). After binding to HER2 on the tumor cell surface, trastuzumab induces an antibody-dependent cell-mediated cytotoxicity against tumor cells that overexpress HER2. HER2 is overexpressed by many adenocarcinomas, particularly breast adenocarcinomas. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B209E1E0-C17C-83F6-E040-BB89AD4339F9","latestVersionIndicator":"Yes","beginDate":"2011-11-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-11-18","modifiedBy":"ONEDATA","dateModified":"2011-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B209E1E0-C18D-83F6-E040-BB89AD4339F9","latestVersionIndicator":"Yes","beginDate":"2011-11-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018810","version":"1","preferredName":"Therapies Specify","preferredDefinition":"the free text field related to therapy.","longName":"TX_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9BA236E-6B3E-350B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"CAMPBELB","dateModified":"2008-03-28","changeDescription":"released as entered during ISO compliance update","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Other, specify","type":"Preferred Question Text","description":"Other, specify","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B209E1E0-C1BD-83F6-E040-BB89AD4339F9","latestVersionIndicator":"Yes","beginDate":"2011-11-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-11-18","modifiedBy":"CAMPBELB","dateModified":"2011-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}